Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Gastroenterology
Published in: Indian Journal of Gastroenterology 1/2020

01-02-2020 | Myelodysplastic Syndrome | Image

Endoscopic findings in a patient with  idiopathic/immune thrombocytopenic purpura: Gastrointestinal bleeding caused by Dieulafoy’s lesion

Authors: Mihoko Yoshida, Yosuke Matsumoto, Hideki Horie, Satoshi Nishimura, Kazuho Shimura, Hiroto Kaneko, Masafumi Taniwaki

Published in: Indian Journal of Gastroenterology | Issue 1/2020

Login to get access

Excerpt

Dieulafoy’s lesion is a rare cause of massive gastrointestinal (GI) bleeding. Life-threatening bleeding occurs in 10% of patients with Dieulafoy’s lesion [1]. Although patients with Dieulafoy’s lesions associated with thrombocytopenia due to hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome [2], myelodysplastic syndrome (MDS) [3], and chronic liver disease [4] have been reported, as far as we know, the case of a patient suffering GI bleeding from Dieulafoy’s lesion with idiopathic/immune thrombocytopenic purpura (ITP) is unprecedented. Here we report a patient with gastrointestinal bleeding caused by Dieulafoy’s lesion in association with ITP. …
Literature
1.
Baxter M, Aly EH. Dieulafoy’s lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010;92:548–54.CrossRef
2.
Si C, Xiuli Z, Li X, et al. Life-threatening bleeding from gastric Dieulafoy’s lesion in a pregnant woman with hellp syndrome: a case report and literature review. BMC Gastroenterol. 2017;17:89.CrossRef
3.
Akar T. Successful hemostasis of an actively bleeding Dieulafoy’s lesion using only argon plasma coagulation in a patient with myelodysplastic syndrome and severe thrombocytopenia. Turk J Gastroenterol. 2017;28:423–4.CrossRef
4.
5.
Hafeez M. Image of the Month. Idiopathic thrombocytopenic pupura. Am J Gastroenterol. 2015;110:1396.CrossRef
Metadata
Title
Endoscopic findings in a patient with  idiopathic/immune thrombocytopenic purpura: Gastrointestinal bleeding caused by Dieulafoy’s lesion
Authors
Mihoko Yoshida
Yosuke Matsumoto
Hideki Horie
Satoshi Nishimura
Kazuho Shimura
Hiroto Kaneko
Masafumi Taniwaki
Publication date
01-02-2020
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 1/2020
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-019-01001-1

Other articles of this Issue 1/2020

Indian Journal of Gastroenterology 1/2020 Go to the issue

Image

Unfolding the diagnosis: A rare presentation of celiac disease in an adult

Review Article

Epidemiology of non-alcoholic fatty liver disease in Asia

Original Article

Natural history, risk factors, and outcome of hepatopulmonary syndrome in pediatric liver diseases

Case Series

Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case series

Original Article

Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity

Original Article

The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits